The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2022

Filed:

Sep. 25, 2018
Applicant:

Qun LU, Greenville, NC (US);

Inventors:

Qun Lu, Greenville, NC (US);

Byron Aguilar, Greenville, NC (US);

Yi Zhu, Greenville, NC (US);

Yan-Hua Chen, Greenville, NC (US);

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/18 (2006.01); A61K 31/166 (2006.01); A61K 31/343 (2006.01); A61K 31/505 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/18 (2013.01); A61K 31/166 (2013.01); A61K 31/343 (2013.01); A61K 31/505 (2013.01); A61P 25/28 (2018.01);
Abstract

Methods of treating Alzheimer's disease and other neurodegenerative and/or neurocognitive and/or neurodevelopmental diseases are described. The methods comprise the administration of compounds that modulate an activity of cell division control protein 42 (Cdc42), such as the interaction between Cdc42 and intersectin (ITSN). Exemplary modulator compounds include thioureas, disulfonamides of fused aromatic systems (e.g., benzofuran), and acyl hydrazones, among others. Some of the modulator compounds act as activators of Cdc42, while others act as inhibitors. In some cases, the modulator compound has dual functionality and the ability of the modulator compound to act as an inhibitor or activator depends on whether or not Cdc42 is already activated in a particular disease stage or biological environment by an upstream activating signal of Cdc42.


Find Patent Forward Citations

Loading…